retatrutide trial weight loss Lilly's triple agonist achieves 16.8% in phase 3 retatrutide weight loss trial retatrutide

Unlike traditional GLP-1 agonists that target a single receptor pathway, tirzepatide simultaneously activates both GLP-1 and glucose-dependent insulinotropic peptide (GIP) receptors

Future research priorities include understanding the long-term effects of senescent cell elimination on tissue homeostasis, regenerative capacity, and overall healthspan, providing foundation for developing sophisticated approaches to aging research and intervention strategies

Bansal Chokdi, Sokhda-363670, Gujarat, India

Next Steps With Everlywell Written by Sendra Yang on November 19, 2023 More On GLP-1s GLP-1s work by imitating the naturally forming GLP-1 hormones in the body

Conklin AI, Yao CA, & Richardson CG

Doctors may choose this route when the goal is to bring the therapy closer to the central nervous system , potentially increasing local exposure